Does TREPROSTINIL Cause Injection site rash? 164 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Injection site rash have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.
164
Reports of Injection site rash with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
1
Deaths
61
Hospitalizations
How Dangerous Is Injection site rash From TREPROSTINIL?
Of the 164 reports, 1 (0.6%) resulted in death, 61 (37.2%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Injection site rash Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
IXEKIZUMAB (526)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
Which TREPROSTINIL Alternatives Have Lower Injection site rash Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE